Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Litchfield

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Progress in Medicinal Chemistry|October 23, 2025
The rise of AlphaFold in drug designAdrian Stecula, Rebecca Paul, Kevin Litchfield, et al.
Cancer Research Communications|March 16, 2023
Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder CancerMateo Sokač, Johanne Ahrenfeldt, Kevin Litchfield, et al.
Nature Reviews. Cancer|December 7, 2023
Fcγ receptors and immunomodulatory antibodies in cancerFelipe Galvez-Cancino, Alexander P Simpson, Cristobal Costoya, et al.
Cancer Discovery|April 3, 2021
Tracking Cancer Evolution through the Disease CourseChris Bailey, James R M Black, James L Reading, et al.
British Journal of Cancer|October 14, 2015
Polygenic susceptibility to testicular cancer: implications for personalised health careKevin Litchfield, Jonathan S Mitchell, Janet Shipley, et al.
British Journal of Cancer|May 27, 2016
Polygenic susceptibility to testicular cancer: implications for personalised health careKevin Litchfield, Jonathan S Mitchell, Janet Shipley, et al.
Cancer Research|April 6, 2022
Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer TypesNeelam Sinha, Sanju Sinha, Cristina Valero, et al.
Journal for Immunotherapy of Cancer|November 9, 2024
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expressionMalte Roerden, Andrea B Castro, Yufei Cui, et al.
Cell|June 13, 2020
Evidence That STK19 Is Not an NRAS-dependent Melanoma DriverMarta Rodríguez-Martínez, Thierry Boissiére, Melvin Noe Gonzalez, et al.
European Urology|February 14, 2018
Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition GeneKevin Litchfield, Chey Loveday, Max Levy, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Progress in Medicinal Chemistry|October 23, 2025
The rise of AlphaFold in drug designAdrian Stecula, Rebecca Paul, Kevin Litchfield, et al.
Cancer Research Communications|March 16, 2023
Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder CancerMateo Sokač, Johanne Ahrenfeldt, Kevin Litchfield, et al.
Nature Reviews. Cancer|December 7, 2023
Fcγ receptors and immunomodulatory antibodies in cancerFelipe Galvez-Cancino, Alexander P Simpson, Cristobal Costoya, et al.
Cancer Discovery|April 3, 2021
Tracking Cancer Evolution through the Disease CourseChris Bailey, James R M Black, James L Reading, et al.
British Journal of Cancer|October 14, 2015
Polygenic susceptibility to testicular cancer: implications for personalised health careKevin Litchfield, Jonathan S Mitchell, Janet Shipley, et al.
British Journal of Cancer|May 27, 2016
Polygenic susceptibility to testicular cancer: implications for personalised health careKevin Litchfield, Jonathan S Mitchell, Janet Shipley, et al.
Cancer Research|April 6, 2022
Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer TypesNeelam Sinha, Sanju Sinha, Cristina Valero, et al.
Journal for Immunotherapy of Cancer|November 9, 2024
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expressionMalte Roerden, Andrea B Castro, Yufei Cui, et al.
Cell|June 13, 2020
Evidence That STK19 Is Not an NRAS-dependent Melanoma DriverMarta Rodríguez-Martínez, Thierry Boissiére, Melvin Noe Gonzalez, et al.
European Urology|February 14, 2018
Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition GeneKevin Litchfield, Chey Loveday, Max Levy, et al.
Pageof 10